A Study for Prevention, Early Detection and Intervention in Acute Kidney Injury Related to Post-Coronary Artery Bypass Grafting Surgery (CABG)

Overview

About this study

The purpose of this study is to see if Nephrology participation in the care of patients undergoing CABG (coronary artery bipass grafting) could reduce the incidence of acute kidney injury through correction of modifiable risk factors, early detection and interventions post-operatively.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria

  • Adult patients (Age >18 years)
  • Elective CABG at Mayo Clinic Rochester and Shanghai Zhongshan Hospital from 7/1/2016 to 6/30/2017

Exclusion Criteria

  • Non-elective CABG
  • Renal failure on dialysis
  • Renal transplantation

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Qi Qian, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available
.
CLS-20260205

Mayo Clinic Footer